{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-062795","form_type":"8-K","ticker":"VTR","cik":"0000740260","company_name":"Ventas, Inc.","filed_at":"2026-05-15T21:15:38+00:00","discovered_at":"2026-05-15T21:16:00.631677+00:00","generated_at":"2026-05-15T21:16:16.166194+00:00","sec_items":["5.02","5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ventas ups ATM equity capacity to $3.0B; all 12 directors elected at annual meeting","bullets":["Amendment No. 3 to ATM Sales Agreement raises aggregate gross sales price to $3.0B, excluding prior sales.","Annual meeting had 93.5% voter turnout; all 12 director nominees elected with majority votes.","Say-on-pay proposal approved with 91.6% of votes cast in favor; KPMG ratification passed.","EVP Peter J. Bulgarelli retired May 1, 2026; separation agreement provides prorated 2026 bonus subject to release and restrictive covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-062795","json":"https://secwatch.observer/filing/0001104659-26-062795.json","markdown":"https://secwatch.observer/filing/0001104659-26-062795.md","text":"https://secwatch.observer/filing/0001104659-26-062795.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/740260/000110465926062795/0001104659-26-062795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/740260/000110465926062795/tm2614646d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:16:16.166194+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"347acdf74b","claim":"Peter J. Bulgarelli retired as Executive Vice President, Outpatient Medical & Research at Ventas, Inc..","evidence_excerpt":"On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/740260/000110465926062795/0001104659-26-062795-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Vice President, Outpatient Medical & Research"}],"fact_type":"executive_change"},{"claim_id":"1b53863a9015c9fbb41a15ea6bef5d0f005ca51c","claim":"Ventas, Inc. shareholders approved To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 3: To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/740260/000110465926062795/0001104659-26-062795-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-13"}],"fact_type":"shareholder_vote"},{"claim_id":"4885ffd96fcf5fd8a13f4e0991e72e46c92d3276","claim":"Ventas, Inc. shareholders approved To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 2: To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/740260/000110465926062795/0001104659-26-062795-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-13"}],"fact_type":"shareholder_vote"},{"claim_id":"a5f0b85615ade75442f48de1de31cb8bc4e47bd9","claim":"Ventas, Inc. shareholders approved To elect the 12 director nominees named in the Proxy Statement to serve until the 2027 Annual Meeting of Stockholders at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 1: To elect the 12 director nominees named in the Proxy Statement to serve until the 2027 Annual Meeting of Stockholders","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/740260/000110465926062795/0001104659-26-062795-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-13"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}